Letrozole
DrugBank ID: DB01006
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| female breast carcinoma | 0.9998 | DL |
| nipple carcinoma | 0.9976 | DL |
| estrogen-receptor negative breast cancer | 0.9975 | DL |
| Ehrlich tumor carcinoma | 0.9975 | DL |
| estrogen-receptor positive breast cancer | 0.9975 | DL |
| hormone-resistant breast carcinoma | 0.9975 | DL |
| bilateral breast carcinoma | 0.9972 | DL |
| breast carcinoma by gene expression profile | 0.9972 | DL |
| breast fibrocystic disease | 0.9962 | DL |
| benign mammary dysplasia | 0.9954 | DL |
| breast abscess | 0.9932 | DL |
| fat necrosis of breast | 0.9932 | DL |
| apocrine adenosis of breast | 0.9931 | DL |
| blunt duct adenosis of breast | 0.9931 | DL |
| lactation disease | 0.9925 | DL |
| breast adenosis | 0.9922 | DL |
| prostate cancer/brain cancer susceptibility | 0.9915 | DL |
| rhabdomyosarcoma (disease) | 0.9907 | DL |
| botryoid-type embryonal rhabdomyosarcoma of the vagina | 0.9901 | DL |
| fibroma of prostate | 0.9899 | DL |
| parameningeal embryonal rhabdomyosarcoma | 0.9898 | DL |
| embryonal extrahepatic bile duct rhabdomyosarcoma | 0.9895 | DL |
| benign reproductive system neoplasm | 0.9894 | DL |
| hereditary breast ovarian cancer syndrome | 0.9894 | DL |
| Brenner tumor | 0.9893 | DL |
| prostate leiomyoma | 0.9891 | DL |
| prostate embryonal rhabdomyosarcoma | 0.9890 | DL |
| extrahepatic bile duct rhabdomyosarcoma | 0.9887 | DL |
| male reproductive organ cancer | 0.9884 | DL |
| liver sarcoma | 0.9876 | DL |
| benign prostate phyllodes tumor | 0.9875 | DL |
| dermatofibrosarcoma protuberans | 0.9826 | DL |
| ovarian clear cell adenocarcinoma | 0.9806 | DL |
| HIV infectious disease | 0.9792 | DL |
| endometrial mixed adenocarcinoma | 0.9784 | DL |
| villoglandular endometrial endometrioid adenocarcinoma | 0.9784 | DL |
| prostate neoplasm | 0.9773 | DL |
| mucin-rich endometrial endometrioid adenocarcinoma | 0.9770 | DL |
| secretory uterine corpus endometrioid adenocarcinoma | 0.9770 | DL |
| AIDS | 0.9758 | DL |
| endometrial mucinous adenocarcinoma | 0.9758 | DL |
| stage I endometrioid carcinoma | 0.9757 | DL |
| stage II endometrioid carcinoma | 0.9757 | DL |
| prostate cancer | 0.9745 | DL |
| cervical endometrioid adenocarcinoma | 0.9743 | DL |
| ovarian endometrioid adenocarcinoma | 0.9741 | DL |
| rete ovarii adenocarcinoma | 0.9739 | DL |
| rectum mucinous adenocarcinoma | 0.9737 | DL |
| malignant prostate phyllodes tumor | 0.9736 | DL |
| colon mucinous adenocarcinoma | 0.9736 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.